RONAWK
Ronawk develops a T-Block technology to produce patient-specific biologics to treat diseases, cancer, organ injuries, and burns by enabling mass production of patient stem cells. The company's proprietary technology provides a break-through method to grow primary stem cells in a 3D environment while maintaining stem cell characteristics of the cell population outside of the body. Its technology enables rapid expansion of stem cells that could be used for early-stage diagnostics or in repairing injured tissues. Ronawk was founded in 2019 and is headquartered in Olathe, Kansas.
RONAWK
Industry:
Biopharma Biotechnology Health Care
Founded:
2019-01-01
Address:
Olathe, Kansas, United States
Country:
United States
Website Url:
http://www.ronawk.com
Total Employee:
1+
Status:
Active
Contact:
316-477-3055
Email Addresses:
[email protected]
Total Funding:
0
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Font API Google Analytics Apple Mobile Web Clips Icon Google Tag Manager WordPress Content Delivery Network
Similar Organizations
Chimeron Bio
Chimeron Bio develops agents for personalized cancer gene therapy.
Fedora Pharmaceuticals
Fedora Pharmaceuticals engages in the discovery and development of antibiotics for life-threatening microbial drug resistance needs.
METiS Therapeutics
METiS Therapeutics uses integrated drug discovery to develop medicines in a variety of illness areas.
Current Employees Featured
Founder
Investors List
MassChallenge
MassChallenge investment in Non Equity Assistance - Ronawk
Official Site Inspections
http://www.ronawk.com
- Host name: 104.21.112.1
- IP address: 104.21.112.1
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago
